<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
<channel>
                    <title>Clinical pharmacology</title>
            <link>https://medicalxpress.com/medications-news/</link>
            <language>en-us</language> 
            <description>Latest medical news and research in Clinical pharmacology</description>

                            <item>
                    <title>Discovering a new layer of control for a decades-old leukemia drug</title>
                    <description>For more than 70 years, the drug 6-thioguanine (6-TG) has been used to treat leukemia. Although its clinical effects have been studied extensively, scientists are still uncovering the molecular mechanisms that determine whether cells succumb to the drug or survive its attack.</description>
                    <link>https://medicalxpress.com/news/2026-08-layer-decades-leukemia-drug.html</link>
                    <category></category>
                    <pubDate>Wed, 12 Aug 2026 18:00:01 EDT</pubDate>
                    <guid isPermaLink="false">news705766741</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/a-new-layer-of-control.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Leucovorin prescriptions for children rise 46% after federal officials&#039; autism claims</title>
                    <description>Leucovorin prescriptions for children spiked after federal officials claimed the drug was an effective treatment for autism during a September 2025 press conference, according to a new Michigan Medicine-led study published in The New England Journal of Medicine.</description>
                    <link>https://medicalxpress.com/news/2026-08-leucovorin-prescriptions-children-federal-autism.html</link>
                    <category></category>
                    <pubDate>Wed, 12 Aug 2026 17:00:03 EDT</pubDate>
                    <guid isPermaLink="false">news705758342</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/tablet-medicine.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Humanized mouse model could significantly improve preclinical research on drugs for celiac disease</title>
                    <description>Celiac disease is an autoimmune disorder in which the immune system reacts to gluten. More than 1% of the population in Germany is affected. In these individuals, gluten proteins found in wheat, rye and barley trigger inflammation in the small intestine, which can damage the intestinal villi and promote disease outside the intestinal tract. Despite following a gluten-free diet, up to 30% of patients with celiac disease still experience symptoms. This is usually due to unavoidable gluten contamination in their daily diet.</description>
                    <link>https://medicalxpress.com/news/2026-08-humanized-mouse-significantly-preclinical-drugs.html</link>
                    <category></category>
                    <pubDate>Wed, 12 Aug 2026 12:00:01 EDT</pubDate>
                    <guid isPermaLink="false">news705747157</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/humanized-mouse-model.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Could salmon and other fatty fish unlock new treatments for severe lung disease?</title>
                    <description>Lung inflammation and injury can quickly turn into acute respiratory distress syndrome (ARDS) in patients with pneumonia, COVID-19 and other conditions.</description>
                    <link>https://medicalxpress.com/news/2026-08-salmon-fatty-fish-treatments-severe.html</link>
                    <category></category>
                    <pubDate>Wed, 12 Aug 2026 11:10:02 EDT</pubDate>
                    <guid isPermaLink="false">news705740924</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/lung-inflammation.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Reinitiating obesity meds after bariatric surgery tied to greater one-year weight loss in youths</title>
                    <description>Restarting obesity medications, including glucagon-like peptide-1 (GLP-1) receptor agonists, soon after sleeve gastrectomy (SG) is associated with greater one-year weight loss than surgery alone in adolescents, according to a research letter published online July 22 in JAMA Surgery.</description>
                    <link>https://medicalxpress.com/news/2026-08-reinitiating-obesity-meds-bariatric-surgery.html</link>
                    <category></category>
                    <pubDate>Tue, 11 Aug 2026 17:40:06 EDT</pubDate>
                    <guid isPermaLink="false">news705678812</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/reinitiating-obesity-m.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>An origami-inspired implant could monitor health from beneath the skin</title>
                    <description>The skin is the body&#039;s largest organ. It is a protective shield that keeps harmful pathogens out and vital fluids inside. These very properties make it a tough engineering challenge to design wearable health sensors because many internal chemical signals cannot easily pass through it.</description>
                    <link>https://medicalxpress.com/news/2026-08-origami-implant-health-beneath-skin.html</link>
                    <category></category>
                    <pubDate>Tue, 11 Aug 2026 15:20:05 EDT</pubDate>
                    <guid isPermaLink="false">news705670400</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/an-origami-inspired-im.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Multiple bioactive compounds drive antimicrobial properties of mānuka honey, study finds</title>
                    <description>New research at Aston University has shown that a variety of compounds are responsible for the antimicrobial action of mānuka honey, not just the sugar content and methylglyoxal (MGO) alone, as previously thought. The paper is published in Microbiology.</description>
                    <link>https://medicalxpress.com/news/2026-08-multiple-bioactive-compounds-antimicrobial-properties.html</link>
                    <category></category>
                    <pubDate>Tue, 11 Aug 2026 12:40:04 EDT</pubDate>
                    <guid isPermaLink="false">news705662761</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2022/manuka-honey.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Cell-surface receptors guide antisense therapy to mutant KRAS in pancreatic cancer cells</title>
                    <description>Antisense oligonucleotides (ASOs) have been proposed as a therapeutic approach to shut down the production of faulty proteins in a wide variety of diseases, including cancer. In a study published in the Journal of Cell Biology (JCB), researchers at the Cancer Research UK Scotland Institute and the University of Glasgow identify a pathway by which ASOs enter cells and reach their targets, suggesting new ways to enhance the effectiveness of antisense therapy.</description>
                    <link>https://medicalxpress.com/news/2026-08-cell-surface-receptors-antisense-therapy.html</link>
                    <category></category>
                    <pubDate>Tue, 11 Aug 2026 10:00:05 EDT</pubDate>
                    <guid isPermaLink="false">news705586562</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/researchers-uncover-pa-1.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Unexpected brain mechanism challenges assumptions about GLP-1s</title>
                    <description>For decades, obesity medications produced only modest weight loss. But in recent years, Ozempic and related GLP-1 therapies have transformed the field, enabling sustained weight loss of 10% to 15% or more. Despite their success, however, scientists have not fully understood how these drugs work in the brain.</description>
                    <link>https://medicalxpress.com/news/2026-08-unexpected-brain-mechanism-assumptions-glp.html</link>
                    <category></category>
                    <pubDate>Mon, 10 Aug 2026 14:00:04 EDT</pubDate>
                    <guid isPermaLink="false">news705583922</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/diet-plate.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Patient-derived organoids reveal which breast tumors may resist standard therapies</title>
                    <description>Researchers at UC San Francisco have developed a new method to predict how different types of breast cancer will respond to treatment, using patient data from the I-SPY2 breast cancer trial and rapid testing on lab-grown mini tumors.</description>
                    <link>https://medicalxpress.com/news/2026-08-patient-derived-organoids-reveal-breast.html</link>
                    <category></category>
                    <pubDate>Mon, 10 Aug 2026 13:40:03 EDT</pubDate>
                    <guid isPermaLink="false">news705583741</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/can-mini-organs-help-p.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Study reveals growing signs of malaria drug resistance in Ethiopia</title>
                    <description>Researchers have identified genetic changes in malaria parasites that may reduce the effectiveness of key antimalarial medicines, highlighting the need for continued surveillance.</description>
                    <link>https://medicalxpress.com/news/2026-08-reveals-malaria-drug-resistance-ethiopia.html</link>
                    <category></category>
                    <pubDate>Mon, 10 Aug 2026 13:20:09 EDT</pubDate>
                    <guid isPermaLink="false">news705583621</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/study-reveals-growing.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>DIY peptide injections are risky</title>
                    <description>DIY peptide injections, which promise to boost everything from weight loss and muscle-building to longevity and sexual health, are a high-risk wellness fad that keeps growing.</description>
                    <link>https://medicalxpress.com/news/2026-08-diy-peptide-risky.html</link>
                    <category></category>
                    <pubDate>Mon, 10 Aug 2026 10:40:01 EDT</pubDate>
                    <guid isPermaLink="false">news705570542</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/peptide-use.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Researchers help identify new Ebola variant and potential treatment</title>
                    <description>When the World Health Organization declared an Ebola outbreak in Uganda and the Democratic Republic of the Congo (DRC) a Public Health Emergency of International Concern in May, scientists around the world mobilized to help. Among them were researchers at Dalhousie University.</description>
                    <link>https://medicalxpress.com/news/2026-08-ebola-variant-potential-treatment.html</link>
                    <category></category>
                    <pubDate>Mon, 10 Aug 2026 07:40:07 EDT</pubDate>
                    <guid isPermaLink="false">news705562501</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/researchers-help-ident.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Study suggests experimental drug dismantles 2 key proteins that help tumors survive, adapt and resist treatment</title>
                    <description>Scientists from Roswell Park Comprehensive Cancer Center report that the investigational anticancer agent FL118 functions as a dual molecular glue degrader that directly targets and degrades the proteins DDX5 and UbE2T, two emerging therapeutic targets linked to cancer survival mechanisms.</description>
                    <link>https://medicalxpress.com/news/2026-08-experimental-drug-dismantles-key-proteins.html</link>
                    <category></category>
                    <pubDate>Mon, 10 Aug 2026 07:20:03 EDT</pubDate>
                    <guid isPermaLink="false">news705561902</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2025/cancer-1.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Triple-dose regimen may permanently clear HIV in infected newborns</title>
                    <description>Every year, more than 120,000 newborns worldwide contract HIV, creating a global health burden that requires lifelong treatment for millions of people—assuming they have access and can afford it. New research led by Oregon Health &amp; Science University suggests another possibility: a one-time regimen of therapies given to newborns within three days of birth to permanently clear the virus. The research is published today in the journal Nature Microbiology.</description>
                    <link>https://medicalxpress.com/news/2026-08-triple-dose-regimen-permanently-hiv.html</link>
                    <category></category>
                    <pubDate>Mon, 10 Aug 2026 05:00:03 EDT</pubDate>
                    <guid isPermaLink="false">news705246781</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/newborn-4.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>New targeting method separates opioid pain relief from reward learning in mice</title>
                    <description>Researchers at Duke University School of Medicine are investigating how to keep opioids&#039; pain-relieving benefits while reducing their addictive potential. In a study published in Nature, they report a step toward that goal.</description>
                    <link>https://medicalxpress.com/news/2026-08-method-opioid-pain-relief-reward.html</link>
                    <category></category>
                    <pubDate>Sun, 09 Aug 2026 06:20:01 EDT</pubDate>
                    <guid isPermaLink="false">news705376931</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2024/opioids-2.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>AI-designed E. coli killer points toward new ways to fight antibiotic-resistant bacteria</title>
                    <description>In science, the suffix &quot;phage&quot; means to devour. Thus, the name bacteriophage might conjure images of tiny creatures that &quot;eat&quot; bacteria. While that conception isn&#039;t 100% scientifically accurate, bacteriophages are lethal killers of bacteria nonetheless, and scientists are excited about engineering phage DNA as a path to new antibiotics.</description>
                    <link>https://medicalxpress.com/news/2026-08-ai-coli-killer-ways-antibiotic.html</link>
                    <category></category>
                    <pubDate>Sat, 08 Aug 2026 07:40:01 EDT</pubDate>
                    <guid isPermaLink="false">news705314866</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/ai-designs-a-novel-e-c.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Malaria vaccine add-ons activate three antibody targets, study finds</title>
                    <description>Malaria kills more than half a million people a year, most of them young children in Africa. Two vaccines are now recommended by the World Health Organization: RTS,S and R21. Both are helpful interventions, but neither works as well or as long as public health officials would like.</description>
                    <link>https://medicalxpress.com/news/2026-08-malaria-vaccine-ons-antibody.html</link>
                    <category></category>
                    <pubDate>Sat, 08 Aug 2026 06:00:01 EDT</pubDate>
                    <guid isPermaLink="false">news705376423</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2023/malaria.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Psychedelics amplify brain connectivity through serotonin receptors, study suggests</title>
                    <description>Psychedelics like psilocybin (from magic mushrooms), LSD, DMT and mescaline profoundly alter how we perceive, feel and think. After decades of neglect, they are again the subject of serious scientific inquiry, largely because of their promise for treating depression, anxiety, addiction and other conditions. But this therapeutic promise has run ahead of a more basic understanding: While a great deal of attention has gone to whether psychedelics help treat mental disorders, far less has gone to what they actually do in a general sense—the fundamental way they change perception, thought and consciousness. Only by understanding these basic mechanisms can we ever make sense of the therapeutic effects.</description>
                    <link>https://medicalxpress.com/news/2026-08-psychedelics-amplify-brain-serotonin-receptors.html</link>
                    <category></category>
                    <pubDate>Fri, 07 Aug 2026 18:00:01 EDT</pubDate>
                    <guid isPermaLink="false">news705324052</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/how-psychedelics-work.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>How drugs leach out of your sweat (and can spoil your sofa)</title>
                    <description>Like all consumer products, sofas come with instructions for how best to use and maintain them. But it may surprise you that many furniture companies warn medicines can seep out in your sweat or body oils and damage your leather sofa.</description>
                    <link>https://medicalxpress.com/news/2026-08-drugs-leach-sofa.html</link>
                    <category></category>
                    <pubDate>Fri, 07 Aug 2026 13:20:01 EDT</pubDate>
                    <guid isPermaLink="false">news705326221</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/how-drugs-leach-out-of.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Omega-3 plus low-dose aspirin produces antibiotic-like results against severe periodontitis</title>
                    <description>A combination of omega-3 and low-dose acetylsalicylic acid (ASA) produced results comparable to antibiotics in treating severe periodontitis. This conclusion is based on a study conducted by researchers affiliated with Albert Einstein Israelite Hospital, Guarulhos University (UNG), the University of Taubaté (UNITAU), and the Ribeirão Preto School of Dentistry at USP (FORP-USP) in Brazil, as well as Harvard University in the United States.</description>
                    <link>https://medicalxpress.com/news/2026-08-omega-dose-aspirin-antibiotic-results.html</link>
                    <category></category>
                    <pubDate>Fri, 07 Aug 2026 12:00:05 EDT</pubDate>
                    <guid isPermaLink="false">news705319681</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2022/dental-care.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Ketamine triggers morning cortisol surge tied to fewer suicidal thoughts—but the link remains uncertain</title>
                    <description>In 1970, ketamine was approved as an anesthetic. It works by blocking receptors in the brain. Suicidal tendencies are among the dangers that accompany severe depression. Doctors have found that a low dose of ketamine, much lower than what is used for anesthesia, can quickly ease depression and suicidal thoughts. It often works within hours to a day, much faster than conventional antidepressants.</description>
                    <link>https://medicalxpress.com/news/2026-08-ketamine-triggers-morning-cortisol-surge.html</link>
                    <category></category>
                    <pubDate>Fri, 07 Aug 2026 07:40:05 EDT</pubDate>
                    <guid isPermaLink="false">news705235353</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/ketamines-cortisol-spi.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>FDA approves first drug for full range of narcolepsy symptoms</title>
                    <description>The U.S. Food and Drug Administration has approved Orzeyful (oveporexton) tablets to treat narcolepsy type 1 in adults. Orzeyful marks the first medication approved for the full range of symptoms associated with narcolepsy type 1 and is the first approved drug to directly target the loss of orexin signaling that causes the disease.</description>
                    <link>https://medicalxpress.com/news/2026-08-fda-drug-full-range-narcolepsy.html</link>
                    <category></category>
                    <pubDate>Thu, 06 Aug 2026 18:00:03 EDT</pubDate>
                    <guid isPermaLink="false">news705255962</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/fda-approves-first-dru.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Finding new osteoarthritis medicines via AI and genetics</title>
                    <description>Osteoarthritis (OA) is a chronic, painful joint disease and a leading cause of disability. Despite its prevalence, therapies for osteoarthritis are limited and focus on symptom management. Now, researchers are combining genetic studies of Utah families with AI-based molecular biology tools to find new medications that may ultimately help treat OA at its source.</description>
                    <link>https://medicalxpress.com/news/2026-08-osteoarthritis-medicines-ai-genetics.html</link>
                    <category></category>
                    <pubDate>Thu, 06 Aug 2026 15:00:05 EDT</pubDate>
                    <guid isPermaLink="false">news705159841</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/osteoarthritis-1.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Why the same antibiotic can cure one infection but fail in another</title>
                    <description>A group of researchers has uncovered why one common antibiotic works for urinary tract infections but often fails elsewhere, offering greater insight into how the body&#039;s own chemistry can determine whether antibiotics succeed or fail.</description>
                    <link>https://medicalxpress.com/news/2026-08-antibiotic-infection.html</link>
                    <category></category>
                    <pubDate>Thu, 06 Aug 2026 14:20:05 EDT</pubDate>
                    <guid isPermaLink="false">news705240601</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/why-the-same-antibioti-1.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>New vaccine strategy protects against chikungunya in mice and could become a platform for combating other diseases</title>
                    <description>An international team of researchers has developed an innovative strategy for producing new vaccines. They created a genetically modified version of the chikungunya virus that replicates only once yet still trains the immune system to defend itself without causing disease. In tests conducted on mice, a single dose of the formulation containing the modified immature virus was sufficient to generate antibodies and protect the rodents against lethal infection.</description>
                    <link>https://medicalxpress.com/news/2026-08-vaccine-strategy-chikungunya-mice-platform.html</link>
                    <category></category>
                    <pubDate>Thu, 06 Aug 2026 12:40:06 EDT</pubDate>
                    <guid isPermaLink="false">news705237781</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/new-vaccine-strategy-p.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Single dose of psilocybin for depression shows promising results in UK&#039;s first publicly funded randomized trial</title>
                    <description>The first randomized controlled trial in the U.K. has found that a single dose of psilocybin, the active compound found in &quot;magic mushrooms,&quot; produced significant improvements in depression compared with a placebo. This is the first publicly funded randomized trial of its kind to deliver the treatment within an NHS setting in England, and it found promising results.</description>
                    <link>https://medicalxpress.com/news/2026-08-dose-psilocybin-depression-results-uk.html</link>
                    <category></category>
                    <pubDate>Thu, 06 Aug 2026 11:20:05 EDT</pubDate>
                    <guid isPermaLink="false">news705229862</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/psychedelic-brain.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Targeting MDA-9 restrains head and neck tumor growth and eliminates therapy resistance</title>
                    <description>Chemotherapy remains a cornerstone of treatment for head and neck cancers, the seventh-most-common type of cancer worldwide. However, the disease is often diagnosed at a late stage, once it has already spread to other organs, and the majority of patients receiving active treatment will develop resistance to chemotherapy within months, underscoring the need for more effective care strategies.</description>
                    <link>https://medicalxpress.com/news/2026-08-mda-restrains-neck-tumor-growth.html</link>
                    <category></category>
                    <pubDate>Thu, 06 Aug 2026 07:20:01 EDT</pubDate>
                    <guid isPermaLink="false">news705213962</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2025/head-and-neck-cancer.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>GLP-1 drug linked to heart benefits for high-risk patients</title>
                    <description>Adding the GLP-1 receptor agonist drug tirzepatide (marketed as Mounjaro) to standard care for patients with type 2 diabetes and heart disease is associated with a lower risk of a major cardiovascular event, such as a heart attack or stroke, finds a study published by The BMJ today.</description>
                    <link>https://medicalxpress.com/news/2026-08-glp-drug-linked-heart-benefits.html</link>
                    <category></category>
                    <pubDate>Wed, 05 Aug 2026 18:30:01 EDT</pubDate>
                    <guid isPermaLink="false">news705074821</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/glp-1-medications.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>New psychedelic candidate may spare the gut while still healing the brain</title>
                    <description>Psychedelic drugs are best known for altering perception and producing vivid hallucinations, but scientists are increasingly interested in what else they might do. A growing body of research suggests that these mind-altering substances could hold real promise as treatments for mental health conditions like depression, acting faster and requiring far fewer doses than standard antidepressants. Despite their promise, today&#039;s psychedelic treatments are often hampered by off-target effects that can cause unwanted side effects.</description>
                    <link>https://medicalxpress.com/news/2026-08-psychedelic-candidate-gut-brain.html</link>
                    <category></category>
                    <pubDate>Wed, 05 Aug 2026 17:00:01 EDT</pubDate>
                    <guid isPermaLink="false">news705161781</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/researchers-engineer-a-3.jpg" width="90" height="90" />
                                    </item>
                    </channel>
</rss>
